FGF23 and COVID-19: Unfortunately, we were unable to obtain biochemical measures of inflammation (C-reactive protein and interleukin-6) and other markers (fibroblast growth factor 23 and prealbumin) in the majority of study participants at all time-points due to the COVID-19 pandemic.